Sanofi initiates Tender Offer for purchasing Bioverativ Inc
Sanofi announced that on February 7, 2018 it commenced a tender offer (the “Offer”) to acquire all of the outstanding...
Roche secure shares in tender offer for Ignyta, Inc
Roche and Ignyta, Inc. today announced that Roche’s wholly owned subsidiary Abingdon Acquisition Corp., has accepted for payment all shares...
Natural History of Diabetes
This editorial is a response to many and many requests to submit a paper on diabetes although I never treated...
Shire presentations at EAHAD 2018 demonstrate commitment to studying outcomes in patients with bleeding disorders
Shire plc , the global biotechnology leader in rare diseases, today announced the range of real-world and long-term research it...
Treatment and Management of Rare Lysosomal Diseases highlighted by shire at Global Conference
Shire plc the global biotechnology leader in rare diseases, today announced that it will have 12 presentations, including 11 posters...
Positive Results from the Pivotal Phase III ‘OPTIMISMM’ Study of POMALYST/IMNOVID
Celgene Corporation announced that the Phase III, randomized, open-label, international clinical study, OPTIMISMM, achieved its primary endpoint, showing a statistically...
Daiichi Sankyo Initiates Phase 1 Study of U3-1402 in Patients with Metastatic EGFR-Mutated Non-Small Cell Lung Cancer
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that the first patient has been dosed in a phase 1 study...
Allergan Announces Positive Top Line Phase 3 Results for Ubrogepant – an Oral CGRP Receptor Antagonist for the Acute Treatment of Migraine.
Allergan plc , a leading global pharmaceutical company today announced positive results from ACHIEVE I (UBR-MD-01), the first of two...
Global Women’s Health Divestiture to CVC Capital Partners completed declares Teva
Teva Pharmaceutical Industries Ltd. announced it has completed the sale of a portfolio of products within its global women’s health...
Teva Completes Amendment to Credit Facilities
Teva Pharmaceutical Industries Ltd. announced amendments to its USD and JPY term loan and revolving credit facilities, providing the company...
Latest News
About Us
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.